David W. Courtman

机构：Ottawa Hospital, Ottawa Hospital Research Institute · ORCID：0000-0002-6403-271X

发表论文 124 篇 · 总被引 4866 次 · h-index 34

代表论文

• Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial (2021 · The Lancet Neurology · 被引 110)
• Extracellular vesicle microRNA and protein cargo profiling in three clinical-grade stem cell products reveals key functional pathways (2023 · Molecular Therapy — Nucleic Acids · 被引 42)
• Prevention of atrial fibrillation after open-chest surgery with extracellular vesicle therapy (2023 · JCI Insight · 被引 25)
• Inactivation of the NLRP3 inflammasome mediates exosome-based prevention of atrial fibrillation (2023 · Theranostics · 被引 21)
• Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury (2022 · Stem Cell Research & Therapy · 被引 13)
• Atrial Fibrosis and Inflammation in Postoperative Atrial Fibrillation (2024 · JACC. Clinical electrophysiology · 被引 11)